About

Dr. Jean Anderson A. Eloy is a Distinguished Professor and Vice Chair of Otolaryngology - Head and Neck Surgery at Rutgers New Jersey Medical School. He serves as the Director of Rhinology and Sinus Surgery, Director of Otolaryngology Research, and Co-Director of the Endoscopic Skull Base Surgery Program. Dr. Eloy also holds joint appointments as Distinguished Professor of Neurological Surgery and Distinguished Professor of Ophthalmology and Visual Sciences at Rutgers New Jersey Medical School. His clinical and surgical expertise includes the medical and surgical management of refractory rhinosinusitis, endoscopic management of sinonasal neoplasia, cerebrospinal fluid rhinorrhea, ventral skull base lesions, endoscopic revision sinus surgery, computer-aided sinus surgery, and functional rhinoplasty. Throughout his career, he has demonstrated a strong commitment to research, education, and patient care, contributing extensively to the fields of Otolaryngology, Neurological Surgery, and Ophthalmology. His scholarly work includes over 490 journal articles, more than 460 peer-reviewed articles, six books, and 43 book chapters, with a focus on Rhinology, Endoscopic Sinus, and Skull Base Surgery. Dr. Eloy has also been involved in over 750 scientific presentations and more than 410 invited lectures and oral presentations at regional, national, and international meetings. He has initiated a fellowship program in Rhinology and Endoscopic Skull Base Surgery, the only such program in New Jersey.

Research topics

• Medicine
• Surgery
• Computer Science
• Family medicine
• Internal medicine
• Political Science
• Pathology
• Law
• Immunology
• Anesthesia
• Emergency medicine
• Psychology
• Medical emergency
• Dermatology
• Biotechnology
• Medical education
• Psychiatry
• Cancer research

Selected publications

• Redefining Research Productivity: Rethinking Applicant Evaluation With the Arms Race Control Score

  Otolaryngology · 2026-04-06

  articleOpen accessSenior author

  OBJECTIVES: The residency application "arms race" for research productivity has intensified following the Step 1 pass/fail transition, with applicants increasingly evaluated by total publication counts. The Total Number of Residency Applicant Publications (TNRAP) has become the dominant metric but doesn't consider authorship position or study quality, leading to inflated and misleading measures of productivity. This study evaluates the Arms Race Control Score (ARCS), a novel effort-adjusted metric, compared to TNRAP in assessing otolaryngology residency applicants. STUDY DESIGN: Retrospective cohort. SETTING: National sample of otolaryngology residency applicants across 5 application cycles (2020-2024). METHODS: A total of 542 matched applicants from 30 programs (10 per US News ranking tier) with PubMed-indexed publications were analyzed. ARCS was calculated by weighting publications by study type, authorship position, and journal impact factor. Trends in TNRAP, cumulative Publication Value Units (cPVU), match characteristics, and ARCS were compared using t-tests, Pearson correlation, and ROC analysis. RESULTS: TNRAP rose significantly from 2020 to 2024 (mean 5.0-8.0; P = .002), while ARCS remained stable (mean ≈ 10; P = .055). ARCS re-ranked 64% to 98% of applicants annually and provided greater discrimination among applicants with identical TNRAP values. ROC analysis demonstrated that ARCS outperformed TNRAP in predicting top 10 match status. CONCLUSIONS: ARCS better reflects research effort and quality than raw counts, offering fairer applicant stratification and stronger predictive consistency for competitive matches. ARCS may mitigate superficial publication, promote meaningful scholarly engagement, and restore balance to the current "arms race" while offering an equitable framework.

  PublisherDOI

• Diagnostic accuracy and citation integrity of four large language models on otolaryngology vignettes

  European Archives of Oto-Rhino-Laryngology · 2026-05-13

  article
  PublisherDOI

• Survival and prognostic factors of anaplastic hemangiopericytoma/solitary fibrous tumor grade III

  Acta Neurochirurgica · 2026-03-27

  articleOpen access

  BACKGROUND: Anaplastic Hemangiopericytoma (AHPC), now known as Solitary Fibrous Tumor (SFT) Grade III, is a rare biologically aggressive neoplasm with a high rate of recurrence. Owing to its rarity, the existing literature is limited regarding its clinical characteristics, prognostic factors, management, and treatment strategies. In this study, we evaluate the association between patient demographics, clinical variables, and treatment modalities with overall survival in patients with intracranial AHPC/SFT Grade III. METHODS: The National Cancer Database (NCDB) was queried for the clinical and care parameters of patients ≥ 18-years-old diagnosed with AHPC between 2004 and 2017. Multivariable Cox proportional hazards model was implemented to determine factors associated with overall survival. RESULTS: 427 patients were identified with a mean age of 52.6 ± 0.7 years. Most patients were between 40-70 years old (67.0%) with patients ≤ 40-years-old making up 21.3% and those ≥ 70-years-old making up only 11.7%. Overall median survival was 10.8 years. When stratified based on age, those ≤ 40-years-old had increased mean survival compared to those ≥ 70-years-old (10.8 vs. 6.6 years; p < 0.001). On multivariable analysis, increasing age (p = 0.006) and the receipt of chemotherapy was associated with decreased overall survival. In contrast, private insurance and managed care (p = 0.021), treatment with surgery alone (p = 0.003), or combined surgery and radiation therapy (p = 0.001) were independently associated with significantly improved overall survival. CONCLUSION: In this NCDB cohort of intracranial grade III SFT/HPC, improved overall survival was associated with younger age, private insurance status, and treatment with surgery alone or surgery combined with radiation therapy. Chemotherapy was not associated with a survival benefit. Interpretation of treatment effects should be cautious, given the potential for selection bias in chemotherapy utilization and the risk of immortal time bias analyses of radiotherapy. Continued advances in therapeutic strategies are needed to further improve survival in this rare and clinically devastating disease.

  PublisherOA PDFDOI

• Surgical Subspecialty and Parathyroidectomy Outcomes: A National Analysis

  Indian Journal of Otolaryngology and Head & Neck Surgery · 2025-04-01

  articleOpen access

  Abstract Aims Parathyroidectomy (PT) is commonly performed for hyperparathyroidism. We investigated the association between surgical subspecialty and adverse outcomes in patients undergoing PT. Materials and methods This retrospective cohort analysis utilized the 2005–2018 National Surgery Quality Improvement Program (NSQIP) database. Current Procedural Terminology (CPT) codes were used to identify cases with a primary procedure of PT. Demographics, comorbidities, and complication incidences were compared between patients undergoing surgery by general surgeons or otolaryngologists using chi-square analyses. The independent effect of surgical subspecialty on adverse outcomes was analyzed using binary logistic regression. Results 49,667 (86.7%) PT performed by general surgeons and 7,595 (13.3%) by otolaryngologists were identified from 2005 to 2018. Chi-square analysis indicated that general surgery patients had lower incidences of obesity (42.0% vs. 44.6%; p &lt; 0.001) and higher incidences of diabetes mellitus (8.1% vs. 5.8%; p &lt; 0.001). Demographic characteristics that significantly differed between cohorts included race ( p &lt; 0.001) and age ( p &lt; 0.001). Unadjusted analyses indicated that otolaryngologist-performed PT had lower incidences of unplanned reoperation (0.9% vs. 1.1%; p = 0.048) and unplanned readmission (2.9% vs. 3.6%; p = 0.009). After adjusting for confounders, logistic regression analyses indicated that otolaryngologist-performed PT had increased odds of prolonged operation time (OR 1.605; 95% CI 1.475–1.746; p &lt; 0.001). Significant differences in mortality, medical complications, and surgical complications were not found. Conclusion Surgical subspecialty is associated with PT operative time but is not associated with perioperative complications.

  PublisherDOI

• Expert Strategies: Skull Base Reconstruction—Global Perspectives, Insights, and Algorithms through a Mixed Methods Approach

  International Forum of Allergy & Rhinology · 2025-05-15 · 3 citations

  articleOpen access

  OBJECTIVE: There is limited consensus on endoscopic skull base surgery (ESBS) reconstruction principles. This study aims to generate comprehensive themes regarding ESBS reconstruction by pooling the experiences of ESBS experts, with comparison to a literature review of current published evidence. METHODS: Structured qualitative interviews of ESBS experts regarding postoperative management and reconstruction of various defect locations were conducted. RESULTS: A total of 68 experts comprising 40 academic teams across 13 countries with an average of 18 years of ESBS experience were included. We propose 10 stepwise algorithms for common skull base reconstruction scenarios based on these expert interviews. When available, the nasoseptal flap is used for all high_flow cerebrospinal leak defects. Multilayered reconstruction is favored at all anatomical subsites with increasing number of layers for increasing defect size and complexity. Heterogeneity exists in terms of inlay technique and materials, free grafting versus various pedicled flap options for low-flow defects or in the absence of a nasal septum, nasal packing, tissue sealant, lumbar drain use, and postoperative management. Commonalities and discrepancies between experts were summarized. CONCLUSION: Skull base reconstruction and post-ESBS management is highly complex with a wide variety of practice patterns and expert strategies. Further research of higher quality evidence is warranted to identify optimal management patterns, though the current work aims to inform surgeons on these controversial areas by drawing from numerous experiences.

  PublisherOA PDFDOI

• Evaluation of Large Language Models' Concordance With Guidelines on Olfaction

  Laryngoscope Investigative Otolaryngology · 2025-03-22

  articleOpen access

  ABSTRACT Objective To assess the concordance of artificial intelligence (AI)‐generated information with the 2022 International Consensus Statement on Allergy and Rhinology: Olfaction (ICAR‐O). Methods Forty‐two guidelines were extracted from the ICAR‐O. Each guideline was converted into a question, which was presented to ChatGPT version 4.o and Google Gemini. Concordance was deemed an agreement between the AI response and the clinical recommendation. Credibility was granted if the AI platform provided a credible resource. Accuracy was graded on a Likert scale (0: entirely inaccurate information, 1: mix of accurate and inaccurate information, 2: entirely accurate information). Statistical analysis was performed. Results A total of 84 responses were generated. The mean accuracy of the ChatGPT and Gemini responses was 1.85 and 1.48 out of 2, respectively, indicating that the responses contained a mix of accurate and inaccurate information. ChatGPT responses were significantly more accurate than Gemini responses ( p = 0.001). Of the ChatGPT responses, 78.57% ( N = 33) were concordant with the ICAR‐O guidelines and 100% ( N = 42) cited a credible resource. Of the Gemini responses, 66.67% ( N = 28) were concordant and 97.62% ( N = 41) cited a credible resource. There were no significant differences in concordance ( p = 0.22) or credibility ( p = 0.31) between the AI platforms. Conclusion ChatGPT provided more accurate information than Gemini on olfaction. However, overall, both platforms did not consistently align with clinical guidelines. AI platforms require further evaluation before clinical implementation or use as educational adjuncts. Level of Evidence N/A.

  PublisherOA PDFDOI

• June 4: International Skull Base Surgery Day

  International Forum of Allergy & Rhinology · 2025-03-26

  editorialOpen access
  PublisherOA PDFDOI

• <scp>RADA</scp> ‐16 Reduces Postoperative Epistaxis After Inferior Turbinate Submucosal Resection

  The Laryngoscope · 2025-05-19 · 3 citations

  articleOpen access

  OBJECTIVES: RADA-16 is a self-assembling peptide matrix with the ability to form a hydrogel structure, showing promise for improved wound healing and hemostasis. Our objective was to understand the utility of RADA-16 on postoperative bleeding rates following inferior turbinate submucosal resection (ITR) surgery. STUDY DESIGN: Retrospective study. METHODS: Electronic health records of patients who underwent ITR surgery with a single surgeon from January 2020 to March 2024 were reviewed. Univariate and multivariate analyses were performed to determine differences in postoperative epistaxis rates between RADA-16 and non-RADA-16 cohorts. Further analysis was performed to compare healthcare-associated costs. RESULTS: Our analysis included 985 patients who underwent ITR, of whom 571 received RADA-16 and 414 did not. Overall, 1.11% of patients experienced postoperative bleeding, 0.35% in the RADA-16 cohort and 2.17% in the non-RADA-16 cohort. Patients receiving RADA-16 had a significantly lower risk of postoperative hemorrhage (OR 0.17, 95% CI 0.036-0.808, p = 0.026). Comparison of the two cohorts showed no significant difference in the prevalence of additional nasal surgery or bleeding disorders. The non-RADA-16 group was more likely to be on anticoagulation treatment (p < 0.001); however, no relationship between anticoagulant usage and bleeding episodes was observed. After cost-effectiveness analysis, we found the bleeding cost per patient was $379.74 for the RADA-16 group and $436.21 for the non-RADA-16 group (p = 0.36). CONCLUSIONS: RADA-16 is believed to improve wound healing and hemostasis. In our study, we found that patients receiving RADA-16 are less likely to experience epistaxis following ITR surgery.

  PublisherOA PDFDOI

• Modified Mini/Hemi/Subtotal/Central Lothrop for Recalcitrant Chronic Frontal Sinusitis

  2025-01-01

  book-chapterSenior author
  PublisherDOI

• Sinonasal Sarcoidosis: A Scoping Review of Demographics, Clinical Presentation, and Outcomes

  Laryngoscope Investigative Otolaryngology · 2025-05-14 · 1 citations

  reviewOpen accessSenior author

  ABSTRACT Objective Sarcoidosis can involve the head and neck and, in particular, the sinonasal tract. We aim to review the presentation, treatment, and outcomes of sinonasal sarcoidosis. Methods A PRISMA‐ScR‐guided scoping review was performed utilizing PubMed, Web of Science, Embase, and SCOPUS to identify case reports describing sarcoidosis in the sinonasal tract. Two reviewers reviewed each article and extracted data. Exclusion criteria consisted of reviews, book chapters, non‐English studies, basic science studies, and animal studies. The following data were extracted: patient demographics, symptoms and duration, biopsy status, angiotensinogen converting enzyme level, imaging, treatment, and outcomes. Results A total of 54 articles (1959–2023) met inclusion criteria, for a total of 103 cases. Median age at diagnosis was 40 years old (18–80 years old). 64% ( N = 67) of patients were female. Most patients were Black ( N = 31, 30%). The most common presenting symptom was nasal obstruction ( N = 54, 50%). 73% ( N = 75) of patients received steroid treatment. 38% ( N = 39) received surgery, the most common procedure being endoscopic sinus surgery (32%, N = 33). Following treatment, 56% ( N = 58) of patients had symptomatic improvement, and 16% ( N = 17) had no change in symptoms or disease. Conclusion Sinonasal sarcoidosis predominantly affects female patients with or without a history of systemic sarcoidosis who present with prolonged nasal obstruction. Most patients have symptomatic improvement with conservative management; however, a select subset of patients may respond well to surgical management. Further investigation into the workup, indications for surgical intervention, and treatment algorithm is warranted to reduce disease morbidity. Level of Evidence NA.

  PublisherOA PDFDOI

Frequent coauthors

• Soly Baredes

  Rutgers, The State University of New Jersey

  965 shared

• James K. Liu

  Rutgers New Jersey Medical School

  620 shared

• Peter F. Svider

  505 shared

• James K. Liu

  Rutgers, The State University of New Jersey

  443 shared

• Christina H. Fang

  Montefiore Medical Center

  387 shared

• Wayne D. Hsueh

  Rutgers, The State University of New Jersey

  293 shared

• Adam J. Folbe

  Michigan United

  260 shared

• Alejandro Vázquez

  University of Tennessee at Knoxville

  175 shared

Education

• M.D.

  UMDNJ-New Jersey Medical School

  2002

• B.S.

  Bloomfield College

  1998

Awards & honors

• Fellow of the American Academy of Otolaryngology - Head and…